Likewise, real-time PCR assay uncovered that LINC01133 was robustly decreased in ER+ breast cancer (BCa, n = 12) relative to corresponding adjacent normal breast tissues (ANT, n = 12) (Figure 1d). The gene discussed is LINC01133; the disease is breast cancer.